Page last updated: 2024-08-23

diltiazem and Adenoma, Basal Cell

diltiazem has been researched along with Adenoma, Basal Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobs, U; Klehr, HU; Klein, B1
Baba, S; Kobayashi, T; Murakami, K; Oimomi, M; Seki, M; Taniguchi, H1
Borges, JL; Davis, M; Drake, C; Iranmanesh, A; Kaiser, DL; Lizzaralde, G; Nassberg, B; Rogol, AD; Santen, RJ; Thorner, MO1

Trials

1 trial(s) available for diltiazem and Adenoma, Basal Cell

ArticleYear
Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas.
    Journal of endocrinological investigation, 1987, Volume: 10, Issue:5

    Topics: Adenoma; Adult; Aged; Calcium; Diltiazem; Humans; Male; Middle Aged; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Pituitary Hormones, Anterior; Pituitary Neoplasms; Random Allocation; Thyrotropin

1987

Other Studies

2 other study(ies) available for diltiazem and Adenoma, Basal Cell

ArticleYear
Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia.
    Transplantation proceedings, 1994, Volume: 26, Issue:6

    Topics: Adenoma; Adult; Aged; Breast Neoplasms, Male; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Synergism; Female; Galactorrhea; Gynecomastia; Humans; Kidney Transplantation; Male; Middle Aged; Nifedipine; Nitrendipine

1994
Suppression of insulin release by calcium antagonist in human insulinoma in vivo and in vitro: its possible role for clinical use.
    The Kobe journal of medical sciences, 1979, Volume: 25, Issue:4

    Topics: Adenoma; Adenoma, Islet Cell; Animals; Calcium; Diltiazem; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Pancreatic Neoplasms; Rats

1979